The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sabba Stephen L since 2011.
This trader's CIK number is 1442372.
At the time of last reporting, Sabba Stephen L was the Officer of Ligand Pharmaceuticals Inc. (stock ticker symbol LGND).
Also see all insider trading activities at Ligand Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | QLTI | 0 | $0 | 0 | $0 | 35,000 | $87,125 |
| 2014 | QLTI | 0 | $0 | 0 | $0 | 2,000 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | LGND | 0 | $0 | 0 | $0 | 2,406 | $125,833 |
| 2024 | LGND | 0 | $0 | 1,893 | $140,649 | 2,893 | $0 |
| 2023 | LGND | 0 | $0 | 6,408 | $494,223 | 6,408 | $0 |
| 2021 | LGND | 0 | $0 | 14,670 | $3,055,394 | 14,670 | $166,137 |
| 2019 | LGND | 0 | $0 | 4,091 | $386,394 | 0 | $0 |
| 2018 | LGND | 0 | $0 | 5,622 | $1,387,664 | 5,000 | $66,150 |
| 2017 | LGND | 0 | $0 | 925 | $126,956 | 0 | $0 |
| 2014 | LGND | 0 | $0 | 500 | $36,125 | 0 | $0 |
| 2011 | LGND | 2,000 | $23,190 | 0 | $0 | 0 | $0 |
1. Novelion Therapeutics Inc. (QLTI)
2. Ligand Pharmaceuticals Inc (LGND)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-06-29 | QLTI | Option Ex | 25,000 | 3.48 | 87,125 |
| 2015-06-07 | QLTI | Option Ex | 10,000 | .00 | 0 |
| 2014-12-15 | QLTI | Option Ex | 2,000 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-04-01 | LGND | Option Ex | 2,406 | 52.30 | 125,833 |
| 2024-03-05 | LGND | Option Ex | 2,893 | .00 | 0 |
| 2024-03-05 | LGND | Sale | 1,893 | 74.30 | 140,649 |
| 2023-05-10 | LGND | Sale | 6,408 | 77.13 | 494,223 |
| 2023-05-10 | LGND | Option Ex | 6,408 | .00 | 0 |
| 2021-02-09 | LGND | Option Ex | 14,670 | 11.32 | 166,137 |
| 2021-02-09 | LGND | Sale | 14,670 | 208.28 | 3,055,394 |
| 2019-07-31 | LGND | Sale | 4,091 | 94.45 | 386,394 |
| 2018-09-04 | LGND | Option Ex | 5,000 | 13.23 | 66,150 |
| 2018-09-04 | LGND | Sale | 5,000 | 255.05 | 1,275,250 |
| 2018-03-12 | LGND | Sale | 622 | 180.73 | 112,414 |
| 2017-12-20 | LGND | Sale | 925 | 137.25 | 126,956 |
| 2014-02-27 | LGND | Sale | 500 | 72.25 | 36,125 |
| 2011-11-14 | LGND | Buy | 1,000 | 11.50 | 11,500 |
| 2011-11-10 | LGND | Buy | 1,000 | 11.69 | 11,690 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sabba Stephen L (Officer of Ligand Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.